{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:56:07Z","timestamp":1790880967380,"version":"4.1.0"},"reference-count":141,"publisher":"Springer Science and Business Media LLC","issue":"S7","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1007\/s00508-016-1126-2","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T07:23:11Z","timestamp":1479972191000},"page":"446-454","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Publication trends in cachexia and sarcopenia in elderly heart failure patients"],"prefix":"10.1007","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5831-4748","authenticated-orcid":false,"given":"Jochen","family":"Springer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D.","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"1126_CR1","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1002\/ejhf.330","volume":"17","author":"A Teixeira","year":"2015","unstructured":"Teixeira A, Parenica J, Park JJ, Ishihara S, AlHabib KF, Laribi S, et\u00a0al. Clinical presentation and outcome by age categories in acute heart failure: results from an international observational cohort. Eur J\u00a0Heart Fail. 2015;17:1114\u201323.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/ehf2.12021","volume":"1","author":"MR Cowie","year":"2014","unstructured":"Cowie MR, Anker SD, Cleland JGF, Felker GM, Filippatos G, Jaarsma T, et\u00a0al. Improving care for patients with acute heart failure: before, during and after hospitalization. Esc Heart Fail. 2014;1:110\u201345.","journal-title":"Esc Heart Fail"},{"key":"1126_CR3","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","volume":"121","author":"D Lloyd-Jones","year":"2010","unstructured":"Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, et al. Executive summary: heart disease and stroke statistics\u00a0\u2013 2010 update: a\u00a0report from the American Heart Association. Circulation. 2010;121:948\u201354.","journal-title":"Circulation"},{"issue":"18","key":"1126_CR4","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"2016","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et\u00a0al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J\u00a0Heart Fail. 2016;2016(18):891\u2013975.","journal-title":"Eur. J. Heart Fail."},{"key":"1126_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ehf2.12005","volume":"1","author":"P Ponikowski","year":"2014","unstructured":"Ponikowski P, Anker SD, AlHabib KF, Cowie MR, Force TL, Hu S, et\u00a0al. Heart failure: preventing disease and death worldwide. ESC Heart Fail. 2014;1:4\u201325.","journal-title":"ESC Heart Fail"},{"key":"1126_CR6","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1002\/ejhf.319","volume":"17","author":"H Shimokawa","year":"2015","unstructured":"Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a\u00a0general pandemic in Asia. Eur J\u00a0Heart Fail. 2015;17:884\u201392.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/ejhf.280","volume":"17","author":"SJ Greene","year":"2015","unstructured":"Greene SJ, Fonarow GC, Solomon SD, Subacius H, Maggioni AP, Bohm M, et al. Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial. Eur J\u00a0Heart Fail. 2015;17:591\u2013600.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1002\/ejhf.283","volume":"17","author":"S Harikrishnan","year":"2015","unstructured":"Harikrishnan S, Sanjay G, Anees T, Viswanathan S, Vijayaraghavan G, Bahuleyan CG, et al. Clinical presentation, management, in-hospital and 90-day outcomes of heart failure patients in Trivandrum, Kerala, India: the Trivandrum Heart Failure Registry. Eur J\u00a0Heart Fail. 2015;17:794\u2013800.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR9","first-page":"e1","volume":"17:767","author":"LK Chen","year":"2016","unstructured":"Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M. Recent advances in sarcopenia research in Asia: 2016 update from the asian working group for sarcopenia. J\u00a0Am Med Dir Assoc. 2016;17:767:e1\u20137.","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"1126_CR10","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ehf2.12103","volume":"3","author":"M Konishi","year":"2016","unstructured":"Konishi M, Ishida J, Springer J, von Haehling S, Akashi YJ, Shimokawa H, et\u00a0al. Heart failure epidemiology and novel treatments in Japan: facts and numbers. ESC Heart Fail. 2016;3:145\u201351.","journal-title":"ESC Heart Fail"},{"key":"1126_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ehf2.12046","volume":"2","author":"M Hassanein","year":"2015","unstructured":"Hassanein M, Abdelhamid M, Ibrahim B, Elshazly A, Aboleineen MW, Sobhy H, et al. Clinical characteristics and management of hospitalized and ambulatory patients with heart failure-results from ESC heart failure long-term registry-Egyptian cohort. ESC Heart Fail. 2015;2:159\u201367.","journal-title":"ESC Heart Fail"},{"key":"1126_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et\u00a0al. Executive summary: heart disease and stroke statistics\u00a0\u2013 2016 update: a\u00a0report from the American Heart Association. Circulation. 2016;133:447\u201354.","journal-title":"Circulation"},{"key":"1126_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s11897-013-0177-1","volume":"11","author":"G Tzanis","year":"2014","unstructured":"Tzanis G, Dimopoulos S, Agapitou V, Nanas S. Exercise intolerance in chronic heart failure: the role of cortisol and the catabolic state. Curr Heart Fail Rep. 2014;11:70\u20139.","journal-title":"Curr Heart Fail Rep"},{"key":"1126_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/ehf2.12055","volume":"2","author":"M Lainscak","year":"2015","unstructured":"Lainscak M, Anker SD. Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges. ESC Heart Fail. 2015;2:103\u20137.","journal-title":"ESC Heart Fail"},{"key":"1126_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.617","author":"D Omersa","year":"2016","unstructured":"Omersa D, Farkas J, Erzen I, Lainscak M. National trends in heart failure hospitalization rates in Slovenia 2004\u20132012. Eur J\u00a0Heart Fail. 2016; doi:\n                    10.1002\/ejhf.617\n                    \n                  .","journal-title":"Eur. J. Heart Fail."},{"key":"1126_CR16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/ehf2.12027","volume":"2","author":"RT Campbell","year":"2015","unstructured":"Campbell RT, Jackson CE, Wright A, Gardner RS, Ford I, Davidson PM, et\u00a0al. Palliative care needs in patients hospitalized with heart failure (PCHF) study: rationale and design. ESC Heart Fail. 2015;2:25\u201336.","journal-title":"ESC Heart Fail"},{"key":"1126_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2217\/fca.13.74","volume":"9","author":"A Kato","year":"2013","unstructured":"Kato A. Muscle wasting is associated with reduced exercise capacity and advanced disease in patients with chronic heart failure. Future Cardiol. 2013;9:767\u201370.","journal-title":"Future Cardiol"},{"key":"1126_CR18","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1002\/ejhf.400","volume":"17","author":"L Steinbeck","year":"2015","unstructured":"Steinbeck L, Ebner N, Valentova M, Bekfani T, Elsner S, Dahinden P, et al. Detection of muscle wasting in patients with chronic heart failure using C\u2011terminal agrin fragment: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). Eur J\u00a0Heart Fail. 2015;17:1283\u201393.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR19","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11897-014-0198-4","volume":"11","author":"I Uchmanowicz","year":"2014","unstructured":"Uchmanowicz I, Loboz-Rudnicka M, Szelag P, Jankowska-Polanska B, Loboz-Grudzien K. Frailty in heart failure. Curr Heart Fail Rep. 2014;11:266\u201373.","journal-title":"Curr Heart Fail Rep"},{"key":"1126_CR20","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/jcsm.12066","volume":"7","author":"P Szulc","year":"2016","unstructured":"Szulc P, Feyt C, Chapurlat R. High risk of fall, poor physical function, and low grip strength in men with fracture-the STRAMBO study. J\u00a0Cachexia Sarcopenia Muscle. 2016;7:299\u2013311.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ehf2.12052","volume":"2","author":"S Yamada","year":"2015","unstructured":"Yamada S, Kamiya K, Kono Y. Frailty may be a\u00a0risk marker for adverse outcome in patients with congestive heart failure. ESC Heart Fail. 2015;2:168\u201370.","journal-title":"ESC Heart Fail"},{"key":"1126_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s13539-014-0161-y","volume":"5","author":"JE Morley","year":"2014","unstructured":"Morley JE, Anker SD, von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:253\u20139.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR23","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1017\/S0029665115002037","volume":"74","author":"VL Keevil","year":"2015","unstructured":"Keevil VL, Romero-Ortuno R. Ageing well: a\u00a0review of sarcopenia and frailty. Proc Nutr Soc. 2015;74:337\u201347.","journal-title":"Proc Nutr Soc"},{"key":"1126_CR24","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/ageing\/afs194","volume":"42","author":"F Landi","year":"2013","unstructured":"Landi F, Cruz-Jentoft AJ, Liperoti R, Russo A, Giovannini S, Tosato M, et al. Sarcopenia and mortality risk in frail older persons aged 80 years and older: results from ilSIRENTE study. Age Ageing. 2013;42:203\u20139.","journal-title":"Age Ageing"},{"key":"1126_CR25","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1038\/ejcn.2014.117","volume":"68","author":"JA Batsis","year":"2014","unstructured":"Batsis JA, Mackenzie TA, Barre LK, Lopez-Jimenez F, Bartels SJ. Sarcopenia, sarcopenic obesity and mortality in older adults: results from the National Health and Nutrition Examination Survey III. Eur J\u00a0Clin Nutr. 2014;68:1001\u20137.","journal-title":"Eur J\u00a0Clin Nutr"},{"key":"1126_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/jcsm.12073","volume":"7","author":"JC Brown","year":"2016","unstructured":"Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a\u00a0population-based sample of community-dwelling older adults. J\u00a0Cachexia Sarcopenia Muscle. 2016;7:290\u20138.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jcsm.12076","volume":"7","author":"S Tyrovolas","year":"2016","unstructured":"Tyrovolas S, Koyanagi A, Olaya B, Ayuso-Mateos JL, Miret M, Chatterji S, et al. Factors associated with skeletal muscle mass, sarcopenia, and sarcopenic obesity in older adults: a\u00a0multi-continent study. J\u00a0Cachexia Sarcopenia Muscle. 2016;7:312\u201321.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-0838.1995.tb00026.x","volume":"5","author":"MM Porter","year":"1995","unstructured":"Porter MM, Vandervoort AA, Lexell J. Aging of human muscle: structure, function and adaptability. Scand J\u00a0Med Sci Sports. 1995;5:129\u201342.","journal-title":"Scand J\u00a0Med Sci Sports"},{"key":"1126_CR29","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/met.2012.0057","volume":"10","author":"T Abe","year":"2012","unstructured":"Abe T, Thiebaud RS, Loenneke JP, Bemben MG, Loftin M, Fukunaga T. Influence of severe sarcopenia on cardiovascular risk factors in nonobese men. Metab Syndr Relat Disord. 2012;10:407\u201312.","journal-title":"Metab Syndr Relat Disord"},{"key":"1126_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/ehf2.12037","volume":"2","author":"F Edelmann","year":"2015","unstructured":"Edelmann F. Facts and numbers on epidemiology and pharmacological treatment of heart failure with preserved ejection fraction. ESC Heart Fail. 2015;2:41\u20135.","journal-title":"ESC Heart Fail"},{"key":"1126_CR31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11897-015-0257-5","volume":"12","author":"B Upadhya","year":"2015","unstructured":"Upadhya B, Haykowsky MJ, Eggebeen J, Kitzman DW. Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2015;12:205\u201314.","journal-title":"Curr Heart Fail Rep"},{"key":"1126_CR32","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1016\/j.ejim.2015.05.016","volume":"26","author":"G Sengul Aycicek","year":"2015","unstructured":"Sengul Aycicek G, Sumer F, Canbaz B, Kara O, Ulger Z. Sarcopenia evaluated by fat-free mass index in patients with chronic heart failure. Eur J\u00a0Intern Med. 2015;26:e34.","journal-title":"Eur. J. Intern. Med."},{"key":"1126_CR33","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ijcard.2016.07.135","volume":"222","author":"T Bekfani","year":"2016","unstructured":"Bekfani T, Pellicori P, Morris DA, Ebner N, Valentova M, Steinbeck L, et\u00a0al. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life. Int J\u00a0Cardiol. 2016;222:41\u20136.","journal-title":"Int J\u00a0Cardiol"},{"key":"1126_CR34","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/ejhf.239","volume":"17","author":"TS Bowen","year":"2015","unstructured":"Bowen TS, Rolim NP, Fischer T, Baekkerud FH, Medeiros A, Werner S, et\u00a0al. Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle. Eur J\u00a0Heart Fail. 2015;17:263\u201372.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR35","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/eurheartj\/ehs381","volume":"34","author":"S Fulster","year":"2013","unstructured":"Fulster S, Tacke M, Sandek A, Ebner N, Tschope C, Doehner W, et al. Muscle wasting in patients with chronic heart failure: results from the studies investigating co-morbidities aggravating heart failure (SICA-HF). Eur Heart J. 2013;34:512\u20139.","journal-title":"Eur. Heart J."},{"key":"1126_CR36","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1536\/ihj.15-108","volume":"56","author":"S Kinugawa","year":"2015","unstructured":"Kinugawa S, Takada S, Matsushima S, Okita K, Tsutsui H. Skeletal muscle abnormalities in heart failure. Int Heart J. 2015;56:475\u201384.","journal-title":"Int Heart J"},{"key":"1126_CR37","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.biocel.2013.04.025","volume":"45","author":"S von Haehling","year":"2013","unstructured":"von Haehling S, Steinbeck L, Doehner W, Springer J, Anker SD. Muscle wasting in heart failure: an overview. Int J\u00a0Biochem Cell Biol. 2013;45:2257\u201365.","journal-title":"Int J\u00a0Biochem Cell Biol"},{"key":"1126_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.ijcard.2012.10.018","volume":"162","author":"MS Anker","year":"2013","unstructured":"Anker MS, von Haehling S, Springer J, Banach M, Anker SD. Highlights of the mechanistic and therapeutic cachexia and sarcopenia research 2010 to 2012 and their relevance for cardiology. Int J\u00a0Cardiol. 2013;162:73\u20136.","journal-title":"Int J\u00a0Cardiol"},{"key":"1126_CR39","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/jcsm.12034","volume":"6","author":"N Mangner","year":"2015","unstructured":"Mangner N, Weikert B, Bowen TS, Sandri M, Hollriegel R, Erbs S, et\u00a0al. Skeletal muscle alterations in chronic heart failure: differential effects on quadriceps and diaphragm. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:381\u201390.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR40","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.healun.2012.12.011","volume":"32","author":"V Agapitou","year":"2013","unstructured":"Agapitou V, Dimopoulos S, Kapelios C, Karatzanos E, Manetos C, Georgantas A, et\u00a0al. Hormonal imbalance in relation to exercise intolerance and ventilatory inefficiency in chronic heart failure. J\u00a0Heart Lung Transplant. 2013;32:431\u20136.","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"1126_CR41","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ehf2.12035","volume":"2","author":"W Doehner","year":"2015","unstructured":"Doehner W, Turhan G, Leyva F, Rauchhaus M, Sandek A, Jankowska EA, et\u00a0al. Skeletal muscle weakness is related to insulin resistance in patients with chronic heart failure. ESC Heart Fail. 2015;2:85\u20139.","journal-title":"ESC Heart Fail"},{"key":"1126_CR42","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1177\/0148607114566854","volume":"40","author":"A Rahman","year":"2016","unstructured":"Rahman A, Jafry S, Jeejeebhoy K, Nagpal AD, Pisani B, Agarwala R. Malnutrition and cachexia in heart failure. JPEN J\u00a0Parenter Enteral Nutr. 2016;40:475\u201386.","journal-title":"JPEN J\u00a0Parenter Enteral Nutr"},{"key":"1126_CR43","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00394-012-0437-y","volume":"52","author":"F Landi","year":"2013","unstructured":"Landi F, Liperoti R, Russo A, Giovannini S, Tosato M, Barillaro C, et al. Association of anorexia with sarcopenia in a\u00a0community-dwelling elderly population: results from the ilSIRENTE study. Eur J\u00a0Nutr. 2013;52:1261\u20138.","journal-title":"Eur J\u00a0Nutr"},{"key":"1126_CR44","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s13539-014-0162-x","volume":"5","author":"H Wakabayashi","year":"2014","unstructured":"Wakabayashi H, Sakuma K. Rehabilitation nutrition for sarcopenia with disability: a\u00a0combination of both rehabilitation and nutrition care management. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:269\u201377.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR45","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/jcsm.12048","volume":"7","author":"TK Malmstrom","year":"2016","unstructured":"Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC-F: a\u00a0symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J\u00a0Cachexia Sarcopenia Muscle. 2016;7:28\u201336.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR46","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/jcsm.12079","volume":"6","author":"JE Morley","year":"2015","unstructured":"Morley JE, Cao L. Rapid screening for sarcopenia. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:312\u20134.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR47","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejim.2015.01.008","volume":"26","author":"T Narumi","year":"2015","unstructured":"Narumi T, Watanabe T, Kadowaki S, Takahashi T, Yokoyama M, Kinoshita D, et al. Sarcopenia evaluated by fat-free mass index is an important prognostic factor in patients with chronic heart failure. Eur J\u00a0Intern Med. 2015;26:118\u201322.","journal-title":"Eur. J. Intern. Med."},{"key":"1126_CR48","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/jcsm.12090","volume":"7","author":"N Scherbakov","year":"2016","unstructured":"Scherbakov N, Doehner W. Searching for a\u00a0relevant definition of sarcopenia: results from the cross-sectional EPIDOS study. J\u00a0Cachexia Sarcopenia Muscle. 2016;7:100\u20131.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/jcsm.12051","volume":"6","author":"R Calvani","year":"2015","unstructured":"Calvani R, Marini F, Cesari M, Tosato M, Anker SD, von Haehling S, et\u00a0al. Biomarkers for physical frailty and sarcopenia: state of the science and future developments. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:278\u201386.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/jcsm.12082","volume":"6","author":"C Drescher","year":"2015","unstructured":"Drescher C, Konishi M, Ebner N, Springer J. Loss of muscle mass: current developments in cachexia and sarcopenia focused on biomarkers and treatment. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:303\u201311.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s13539-013-0120-z","volume":"5","author":"MS Fragala","year":"2014","unstructured":"Fragala MS, Jajtner AR, Beyer KS, Townsend JR, Emerson NS, Scanlon TC, et al. Biomarkers of muscle quality: N\u2011terminal propeptide of type III procollagen and C\u2011terminal agrin fragment responses to resistance exercise training in older adults. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:139\u201348.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR52","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.cca.2014.06.022","volume":"436","author":"T Martins","year":"2014","unstructured":"Martins T, Vitorino R, Amado F, Duarte JA, Ferreira R. Biomarkers for cardiac cachexia: reality or utopia. Clin Chim Acta. 2014;436:323\u20138.","journal-title":"Clin. Chim. Acta"},{"key":"1126_CR53","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/ejhf.437","volume":"17","author":"G Vescovo","year":"2015","unstructured":"Vescovo G. Neuromuscular junction fragmentation and muscle wasting in heart failure: a\u00a0sharp cut from a\u00a0Sica sword? Eur J\u00a0Heart Fail. 2015;17:1216\u20138.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR54","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.clnu.2014.03.007","volume":"33","author":"G Biolo","year":"2014","unstructured":"Biolo G, Cederholm T, Muscaritoli M. Muscle contractile and metabolic dysfunction is a\u00a0common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia. Clin Nutr (edinburgh Scotland). 2014;33:737\u201348.","journal-title":"Clin Nutr (edinburgh Scotland)"},{"key":"1126_CR55","doi-asserted-by":"publisher","first-page":"58","DOI":"10.2174\/1871530311313010008","volume":"13","author":"M Zamboni","year":"2013","unstructured":"Zamboni M, Rossi AP, Corzato F, Bambace C, Mazzali G, Fantin F. Sarcopenia, cachexia and congestive heart failure in the elderly. Endocr Metab Immune Disord Drug Targets. 2013;13:58\u201367.","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1126_CR56","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ejhf.240","volume":"17","author":"P Rossignol","year":"2015","unstructured":"Rossignol P, Masson S, Barlera S, Girerd N, Castelnovo A, Zannad F, et al. Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trials. Eur J\u00a0Heart Fail. 2015;17:424\u201333.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR57","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ejhf.289","volume":"17","author":"A Mebazaa","year":"2015","unstructured":"Mebazaa A, Yilmaz MB, Levy P, Ponikowski P, Peacock WF, Laribi S, et al. Recommendations on pre-hospital & early hospital management of acute heart failure: a\u00a0consensus paper from the Heart Failure Association of the European Society of Cardiology, the European Society of Emergency Medicine and the Society of Academic Emergency Medicine. Eur J\u00a0Heart Fail. 2015;17:544\u201358.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR58","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s12020-012-9836-3","volume":"43","author":"HM Christensen","year":"2013","unstructured":"Christensen HM, Kistorp C, Schou M, Keller N, Zerahn B, Frystyk J, et\u00a0al. Prevalence of cachexia in chronic heart failure and characteristics of body composition and metabolic status. Endocrine. 2013;43:626\u201334.","journal-title":"Endocrine"},{"key":"1126_CR59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s13539-014-0164-8","volume":"5","author":"S von Haehling","year":"2014","unstructured":"von Haehling S, Anker SD. Prevalence, incidence and clinical impact of cachexia: facts and numbers-update 2014. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:261\u20133.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR60","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0140-6736(96)07015-8","volume":"349","author":"SD Anker","year":"1997","unstructured":"Anker SD, Ponikowski P, Varney S, Chua TP, Clark AL, Webb-Peploe KM, et al. Wasting as independent risk factor for mortality in chronic heart failure. Lancet (london England). 1997;349:1050\u20133.","journal-title":"Lancet (london England)"},{"key":"1126_CR61","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1002\/ejhf.118","volume":"16","author":"J Altenberger","year":"2014","unstructured":"Altenberger J, Parissis JT, Costard-Jaeckle A, Winter A, Ebner C, Karavidas A, et al. Efficacy and safety of the pulsed infusions of levosimendan in outpatients with advanced heart failure (LevoRep) study: a\u00a0multicentre randomized trial. Eur J\u00a0Heart Fail. 2014;16:898\u2013906.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR62","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1002\/ejhf.300","volume":"17","author":"SD Anker","year":"2015","unstructured":"Anker SD, Kosiborod M, Zannad F, Pina IL, McCullough PA, Filippatos G, et al. Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a\u00a0phase 3 randomized, double-blind, placebo-controlled trial. Eur J\u00a0Heart Fail. 2015;17:1050\u20136.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR63","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ejhf.85","volume":"16","author":"M Bohm","year":"2014","unstructured":"Bohm M, Perez AC, Jhund PS, Reil JC, Komajda M, Zile MR, et al. Relationship between heart rate and mortality and morbidity in the irbesartan patients with heart failure and preserved systolic function trial (I-Preserve). Eur J\u00a0Heart Fail. 2014;16:778\u201387.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR64","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1016\/S0140-6736(16)30137-4","volume":"387","author":"AN Patel","year":"2016","unstructured":"Patel AN, Henry TD, Quyyumi AA, Schaer GL, Anderson RD, Toma C, et al. Ixmyelocel-T for patients with ischaemic heart failure: a\u00a0prospective randomised double-blind trial. Lancet (london England). 2016;387:2412\u201321.","journal-title":"Lancet (london England)"},{"key":"1126_CR65","doi-asserted-by":"publisher","first-page":"e002764","DOI":"10.1161\/CIRCHEARTFAILURE.115.002764","volume":"9","author":"I Olivotto","year":"2016","unstructured":"Olivotto I, Hellawell JL, Farzaneh-Far R, Blair C, Coppini R, Myers J, et al. Novel approach targeting the complex pathophysiology of hypertrophic cardiomyopathy: the impact of late sodium current inhibition on exercise capacity in subjects with symptomatic hypertrophic cardiomyopathy (LIBERTY-HCM) trial. Circ Heart Fail. 2016;9:e002764.","journal-title":"Circ Heart Fail"},{"key":"1126_CR66","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.amjcard.2015.10.059","volume":"117","author":"RJ Mentz","year":"2016","unstructured":"Mentz RJ, Hasselblad V, DeVore AD, Metra M, Voors AA, Armstrong PW, et al. Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF trial). Am J\u00a0Cardiol. 2016;117:404\u201311.","journal-title":"Am J\u00a0Cardiol"},{"key":"1126_CR67","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/ejhf.340","volume":"17","author":"P Pellicori","year":"2015","unstructured":"Pellicori P, Clark AL. Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure. Eur J\u00a0Heart Fail. 2015;17:979\u201383.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR68","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ejhf.256","volume":"17","author":"JO Choi","year":"2015","unstructured":"Choi JO, Daly RC, Lin G, Lahr BD, Wiste HJ, Beaver TM, et al. Impact of surgical ventricular reconstruction on sphericity index in patients with ischaemic cardiomyopathy: follow-up from the STICH trial. Eur J\u00a0Heart Fail. 2015;17:453\u201363.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR69","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/ejhf.116","volume":"16","author":"AC Morley-Smith","year":"2014","unstructured":"Morley-Smith AC, Mills A, Jacobs S, Meyns B, Rega F, Simon AR, et al. Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a\u00a0left ventricular assist device. Eur J\u00a0Heart Fail. 2014;16:871\u20139.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR70","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/ejhf.168","volume":"16","author":"M Tremblay-Gravel","year":"2014","unstructured":"Tremblay-Gravel M, Khairy P, Roy D, Leduc H, Wyse DG, Cadrin-Tourigny J, et al. Systolic blood pressure and mortality in patients with atrial fibrillation and heart failure: insights from the AFFIRM and AF-CHF studies. Eur J\u00a0Heart Fail. 2014;16:1168\u201374.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR71","doi-asserted-by":"publisher","first-page":"883","DOI":"10.5966\/sctm.2015-0241","volume":"5","author":"U Agarwal","year":"2016","unstructured":"Agarwal U, Smith AW, French KM, Boopathy AV, George A, Trac D, et al. Age-dependent effect of pediatric cardiac progenitor cells after juvenile heart failure. Stem Cells Transl Med. 2016;5:883\u201392.","journal-title":"Stem Cells Transl Med"},{"key":"1126_CR72","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.115.018852","volume":"133","author":"LH Connors","year":"2016","unstructured":"Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: a\u00a0prospective, observational cohort study. Circulation. 2016;133:282\u201390.","journal-title":"Circulation"},{"key":"1126_CR73","doi-asserted-by":"publisher","first-page":"e0145958","DOI":"10.1371\/journal.pone.0145958","volume":"11","author":"HH Le","year":"2016","unstructured":"Le HH, El-Khatib C, Mombled M, Guitarian F, Al-Gobari M, Fall M, et al. Impact of aldosterone antagonists on sudden cardiac death prevention in heart failure and post-myocardial infarction patients: a\u00a0systematic review and meta-analysis of randomized controlled trials. PLOS ONE. 2016;11:e0145958.","journal-title":"PLOS ONE"},{"key":"1126_CR74","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1016\/j.jacc.2016.02.042","volume":"67","author":"HA Jamil","year":"2016","unstructured":"Jamil HA, Gierula J, Paton MF, Byrom R, Lowry JE, Cubbon RM, et\u00a0al. Chronotropic incompetence does not limit exercise capacity in chronic heart failure. J\u00a0Am Coll Cardiol. 2016;67:1885\u201396.","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"1126_CR75","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/j.jacc.2016.01.069","volume":"67","author":"GW Stone","year":"2016","unstructured":"Stone GW, Selker HP, Thiele H, Patel MR, Udelson JE, Ohman EM, et al. Relationship between infarct size and outcomes following primary PCI: patient-level analysis from 10 randomized trials. J\u00a0Am Coll Cardiol. 2016;67:1674\u201383.","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"1126_CR76","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1056\/NEJMoa1606599","volume":"375","author":"RD McEvoy","year":"2016","unstructured":"McEvoy RD, Antic NA, Heeley E, Luo Y, Ou Q, Zhang X, et\u00a0al. CPAP for prevention of cardiovascular events in obstructive sleep apnea. N\u00a0Engl J\u00a0Med. 2016;375:919\u201331.","journal-title":"N\u00a0Engl J\u00a0Med"},{"key":"1126_CR77","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.2215\/CJN.00620115","volume":"10","author":"U Hoke","year":"2015","unstructured":"Hoke U, Khidir MJ, van der Velde ET, Schalij MJ, Bax JJ, Delgado V, et\u00a0al. Cardiac resynchronization therapy in CKD stage 4 patients. Clinical journal of the american society of nephrology. Clin J\u00a0Am Soc Nephrol. 2015;10:1740\u20138.","journal-title":"Clin J\u00a0Am Soc Nephrol"},{"key":"1126_CR78","doi-asserted-by":"publisher","first-page":"h3529","DOI":"10.1136\/bmj.h3529","volume":"351","author":"CY Chen","year":"2015","unstructured":"Chen CY, Stevenson LW, Stewart GC, Bhatt DL, Desai M, Seeger JD, et al. Real world effectiveness of primary implantable cardioverter defibrillators implanted during hospital admissions for exacerbation of heart failure or other acute co-morbidities: cohort study of older patients with heart failure. BMJ. 2015;351:h3529.","journal-title":"BMJ"},{"key":"1126_CR79","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1093\/eurheartj\/ehv189","volume":"36","author":"P Menasche","year":"2015","unstructured":"Menasche P, Vanneaux V, Hagege A, Bel A, Cholley B, Cacciapuoti I, et al. Human embryonic stem cell-derived cardiac progenitors for severe heart failure treatment: first clinical case report. Eur Heart J. 2015;36:2011\u20137.","journal-title":"Eur. Heart J."},{"key":"1126_CR80","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jcsm.12108","volume":"7","author":"D Berger","year":"2016","unstructured":"Berger D, Bloechlinger S, von Haehling S, Doehner W, Takala J, Z\u2019Graggen WJ, et\u00a0al. Dysfunction of respiratory muscles in critically ill patients on the intensive care unit. J\u00a0Cachexia Sarcopenia Muscle. 2016;7:403\u201312.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s13539-010-0010-6","volume":"1","author":"JC Schefold","year":"2010","unstructured":"Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J\u00a0Cachexia Sarcopenia Muscle. 2010;1:147\u201357.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR82","first-page":"884","volume":"30","author":"MC Kizilarslanoglu","year":"2016","unstructured":"Kizilarslanoglu MC, Kuyumcu ME, Yesil Y, Halil M. Sarcopenia in critically ill patients. J\u00a0Anesth. 2016;30:884\u201390.","journal-title":"J\u00a0Anesth"},{"key":"1126_CR83","doi-asserted-by":"publisher","unstructured":"Jolley SE, Bunnell A, Hough CL. Intensive care unit acquired weakness. Chest. 2016. doi:\n                    10.1016\/j.chest.2016.03.045\n                    \n                  .","DOI":"10.1016\/j.chest.2016.03.045"},{"key":"1126_CR84","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.arr.2010.04.004","volume":"9","author":"TW Buford","year":"2010","unstructured":"Buford TW, Anton SD, Judge AR, Marzetti E, Wohlgemuth SE, Carter CS, et al. Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy. Ageing Res Rev. 2010;9:369\u201383.","journal-title":"Ageing Res. Rev."},{"key":"1126_CR85","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/ehf2.12033","volume":"2","author":"N Ebner","year":"2015","unstructured":"Ebner N, Sliziuk V, Scherbakov N, Sandek A. Muscle wasting in ageing and chronic illness. ESC Heart Fail. 2015;2:58\u201368.","journal-title":"ESC Heart Fail"},{"key":"1126_CR86","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijcard.2016.07.167","volume":"222","author":"KP Izawa","year":"2016","unstructured":"Izawa KP, Watanabe S, Oka K, Kasahara Y, Morio Y, Hiraki K, et\u00a0al. Sarcopenia and physical activity in older male cardiac patients. Int J\u00a0Cardiol. 2016;222:457\u201361.","journal-title":"Int J\u00a0Cardiol"},{"key":"1126_CR87","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/ehf2.12028","volume":"2","author":"A Abdelmawgoud","year":"2015","unstructured":"Abdelmawgoud A, Brown CJ, Sui X, Fonarow GC, Kokkinos PF, Bittner V, et al. Relationship of physical activity and healthy eating with mortality and incident heart failure among community-dwelling older adults with normal body mass index. ESC Heart Fail. 2015;2:20\u20134.","journal-title":"ESC Heart Fail"},{"key":"1126_CR88","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/jcsm.12021","volume":"6","author":"C Dupuy","year":"2015","unstructured":"Dupuy C, Lauwers-Cances V, Guyonnet S, Gentil C, Abellan Van Kan G, Beauchet O, et al. Searching for a\u00a0relevant definition of sarcopenia: results from the cross-sectional EPIDOS study. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:144\u201354.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR89","first-page":"755","volume":"147","author":"RN Baumgartner","year":"1998","unstructured":"Baumgartner RN, Koehler KM, Gallagher D, Romero L, Heymsfield SB, Ross RR, et\u00a0al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J\u00a0Epidemiol. 1998;147:755\u201363.","journal-title":"Am J\u00a0Epidemiol"},{"key":"1126_CR90","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","volume":"39","author":"AJ Cruz-Jentoft","year":"2010","unstructured":"Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: report of the european working group on sarcopenia in older people. Age Ageing. 2010;39:412\u201323.","journal-title":"Age Ageing"},{"key":"1126_CR91","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","volume":"51","author":"AB Newman","year":"2003","unstructured":"Newman AB, Kupelian V, Visser M, Simonsick E, Goodpaster B, Nevitt M, et\u00a0al. Sarcopenia: alternative definitions and associations with lower extremity function. J\u00a0Am Geriatr Soc. 2003;51:1602\u20139.","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"1126_CR92","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1532-5415.2007.01140.x","volume":"55","author":"MJ Delmonico","year":"2007","unstructured":"Delmonico MJ, Harris TB, Lee JS, Visser M, Nevitt M, Kritchevsky SB, et\u00a0al. Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J\u00a0Am Geriatr Soc. 2007;55:769\u201374.","journal-title":"J\u00a0Am Geriatr Soc"},{"key":"1126_CR93","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","volume":"29","author":"M Muscaritoli","year":"2010","unstructured":"Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d. Clin Nutr. 2010;29:154\u20139.","journal-title":"Clin Nutr"},{"key":"1126_CR94","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","volume":"12","author":"RA Fielding","year":"2011","unstructured":"Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et\u00a0al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J\u00a0Am Med Dir Assoc. 2011;12:249\u201356.","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"1126_CR95","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/gerona\/glu013","volume":"69","author":"TT Dam","year":"2014","unstructured":"Dam TT, Peters KW, Fragala M, Cawthon PM, Harris TB, McLean R, et al. An evidence-based comparison of operational criteria for the presence of sarcopenia. J\u00a0Gerontol Ser A\u00a0Biol Sci Med Sci. 2014;69:584\u201390.","journal-title":"J\u00a0Gerontol Ser A\u00a0Biol Sci Med Sci"},{"key":"1126_CR96","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jamda.2015.05.021","volume":"16","author":"JM Bauer","year":"2015","unstructured":"Bauer JM, Verlaan S, Bautmans I, Brandt K, Donini LM, Maggio M, et al. Effects of a\u00a0vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a\u00a0randomized, double-blind, placebo-controlled trial. J\u00a0Am Med Dir Assoc. 2015;16:740\u20137.","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"1126_CR97","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.jocd.2015.04.011","volume":"18","author":"S Phu","year":"2015","unstructured":"Phu S, Boersma D, Duque G. Exercise and Sarcopenia. J\u00a0Clin Densitom. 2015;18:488\u201392.","journal-title":"J\u00a0Clin Densitom"},{"key":"1126_CR98","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/jcsm.12043","volume":"6","author":"TS Bowen","year":"2015","unstructured":"Bowen TS, Schuler G, Adams V. Skeletal muscle wasting in cachexia and sarcopenia: molecular pathophysiology and impact of exercise training. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:197\u2013207.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR99","doi-asserted-by":"publisher","unstructured":"Vitale G, Cesari M, Mari D. Aging of the endocrine system and its potential impact on sarcopenia. Eur J\u00a0Intern Med. 2016. doi:\n                    10.1016\/j.ejim.2016.07.017\n                    \n                  .","DOI":"10.1016\/j.ejim.2016.07.017"},{"key":"1126_CR100","doi-asserted-by":"publisher","first-page":"452","DOI":"10.3945\/an.115.008367","volume":"6","author":"SM Phillips","year":"2015","unstructured":"Phillips SM. Nutritional supplements in support of resistance exercise to counter age-related sarcopenia. Adv Nutr. 2015;6:452\u201360.","journal-title":"Adv Nutr"},{"issue":"Suppl","key":"1126_CR101","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.3177\/jnsv.61.S125","volume":"61","author":"Y Makanae","year":"2015","unstructured":"Makanae Y, Fujita S. Role of exercise and nutrition in the prevention of sarcopenia. J\u00a0Nutr Sci Vitaminol. 2015;61(Suppl):S125\u2013S127.","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"1126_CR102","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s10549-016-3900-2","volume":"158","author":"SC Adams","year":"2016","unstructured":"Adams SC, Segal RJ, McKenzie DC, Vallerand JR, Morielli AR, Mackey JR, et\u00a0al. Impact of resistance and aerobic exercise on sarcopenia and dynapenia in breast cancer patients receiving adjuvant chemotherapy: a\u00a0multicenter randomized controlled trial. Breast Cancer Res Treat. 2016;158:497\u2013507.","journal-title":"Breast Cancer Res Treat"},{"key":"1126_CR103","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/jcsm.12030","volume":"6","author":"E Gielen","year":"2015","unstructured":"Gielen E, O\u2019Neill TW, Pye SR, Adams JE, Wu FC, Laurent MR, et al. Endocrine determinants of incident sarcopenia in middle-aged and elderly European men. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:242\u201352.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR104","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.pcad.2014.10.001","volume":"57","author":"S Gielen","year":"2015","unstructured":"Gielen S, Laughlin MH, O\u2019Conner C, Duncker DJ. Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis. 2015;57:347\u201355.","journal-title":"Prog Cardiovasc Dis"},{"key":"1126_CR105","doi-asserted-by":"publisher","first-page":"e110020","DOI":"10.1371\/journal.pone.0110020","volume":"9","author":"RW Souza","year":"2014","unstructured":"Souza RW, Piedade WP, Soares LC, Souza PA, Aguiar AF, Vechetti-Junior IJ, et al. Aerobic exercise training prevents heart failure-induced skeletal muscle atrophy by anti-catabolic, but not anabolic actions. PLOS ONE. 2014;9:e110020.","journal-title":"PLOS ONE"},{"key":"1126_CR106","doi-asserted-by":"publisher","first-page":"e41701","DOI":"10.1371\/journal.pone.0041701","volume":"7","author":"TF Cunha","year":"2012","unstructured":"Cunha TF, Bacurau AV, Moreira JB, Paixao NA, Campos JC, Ferreira JC, et al. Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLOS ONE. 2012;7:e41701.","journal-title":"PLOS ONE"},{"key":"1126_CR107","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.ijcard.2012.03.083","volume":"167","author":"R Hollriegel","year":"2013","unstructured":"Hollriegel R, Beck EB, Linke A, Adams V, Mobius-Winkler S, Mangner N, et al. Anabolic effects of exercise training in patients with advanced chronic heart failure (NYHA IIIb): impact on ubiquitin-protein ligases expression and skeletal muscle size. Int J\u00a0Cardiol. 2013;167:975\u201380.","journal-title":"Int J\u00a0Cardiol"},{"key":"1126_CR108","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1161\/CIRCULATIONAHA.111.047381","volume":"125","author":"S Gielen","year":"2012","unstructured":"Gielen S, Sandri M, Kozarez I, Kratzsch J, Teupser D, Thiery J, et al. Exercise training attenuates MuRF-1 expression in the skeletal muscle of patients with chronic heart failure independent of age: the randomized Leipzig Exercise Intervention in Chronic Heart Failure and Aging catabolism study. Circulation. 2012;125:2716\u201327.","journal-title":"Circulation"},{"key":"1126_CR109","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1113\/expphysiol.2013.076844","volume":"99","author":"PC Brum","year":"2014","unstructured":"Brum PC, Bacurau AV, Cunha TF, Bechara LR, Moreira JB. Skeletal myopathy in heart failure: effects of aerobic exercise training. Exp Physiol. 2014;99:616\u201320.","journal-title":"Exp Physiol"},{"key":"1126_CR110","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1161\/CIRCHEARTFAILURE.113.000841","volume":"7","author":"M Okutsu","year":"2014","unstructured":"Okutsu M, Call JA, Lira VA, Zhang M, Donet JA, French BA, et\u00a0al. Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure. Circ Heart Fail. 2014;7:519\u201330.","journal-title":"Circ Heart Fail"},{"key":"1126_CR111","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1741826711402735","volume":"19","author":"K Lenk","year":"2012","unstructured":"Lenk K, Erbs S, Hollriegel R, Beck E, Linke A, Gielen S, et\u00a0al. Exercise training leads to a\u00a0reduction of elevated myostatin levels in patients with chronic heart failure. Eur J\u00a0Prev Cardiol. 2012;19:404\u201311.","journal-title":"Eur J\u00a0Prev Cardiol"},{"key":"1126_CR112","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12109","author":"TD Trippel","year":"2016","unstructured":"Trippel TD, Holzendorf V, Halle M, Gelbrich G, Nolte K, Duvinage A, et al. Ghrelin and hormonal markers under exercise training in patients with heart failure with preserved ejection fraction: results from the Ex-DHF pilot study. ESC Heart Fail. 2016; doi:\n                    10.1002\/ehf2.12109\n                    \n                  .","journal-title":"ESC Heart Fail"},{"key":"1126_CR113","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ejhf.305","volume":"17","author":"T Jaarsma","year":"2015","unstructured":"Jaarsma T, Klompstra L, Ben GT, Boyne J, Vellone E, Back M, et al. Increasing exercise capacity and quality of life of patients with heart failure through Wii gaming: the rationale, design and methodology of the HF-Wii study; a\u00a0multicentre randomized controlled trial. Eur J\u00a0Heart Fail. 2015;17:743\u20138.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR114","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s12170-013-0353-6","volume":"7","author":"G Azhar","year":"2013","unstructured":"Azhar G, Wei JY. New approaches to treating cardiac cachexia in the older patient. Curr Cardiovasc Risk Rep. 2013;7:480\u20134.","journal-title":"Curr Cardiovasc Risk Rep"},{"key":"1126_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12117","author":"M Konishi","year":"2016","unstructured":"Konishi M, Ishida J, Springer J, Anker SD, von Haehling S. Cachexia research in Japan: facts and numbers on prevalence, incidence and clinical impact. J\u00a0Cachexia Sarcopenia Muscle. 2016; doi:\n                    10.1002\/jcsm.12117\n                    \n                  .","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR116","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/SPC.0000000000000222","volume":"10","author":"D Dudgeon","year":"2016","unstructured":"Dudgeon D, Baracos VE. Physiological and functional failure in chronic obstructive pulmonary disease, congestive heart failure and cancer: a\u00a0debilitating intersection of sarcopenia, cachexia and breathlessness. Curr Opin Support Palliat Care. 2016;10:236\u201341.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1126_CR117","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","volume":"5","author":"MS Potsch","year":"2014","unstructured":"Potsch MS, Tschirner A, Palus S, von Haehling S, Doehner W, Beadle J, et\u00a0al. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:149\u201358.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR118","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s13539-014-0137-y","volume":"5","author":"SM Kazemi-Bajestani","year":"2014","unstructured":"Kazemi-Bajestani SM, Becher H, Fassbender K, Chu Q, Baracos VE. Concurrent evolution of cancer cachexia and heart failure: bilateral effects exist. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:95\u2013104.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR119","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.clinbiochem.2013.10.025","volume":"47","author":"T Martins","year":"2014","unstructured":"Martins T, Vitorino R, Moreira-Goncalves D, Amado F, Duarte JA, Ferreira R. Recent insights on the molecular mechanisms and therapeutic approaches for cardiac cachexia. Clin Biochem. 2014;47:8\u201315.","journal-title":"Clin Biochem"},{"key":"1126_CR120","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/nu8070442","volume":"8","author":"E Sciatti","year":"2016","unstructured":"Sciatti E, Lombardi C, Ravera A, Vizzardi E, Bonadei I, Carubelli V, et\u00a0al. Nutritional deficiency in patients with heart failure. Nutrients. 2016;8:442. doi:\n                    10.3390\/nu8070442\n                    \n                  .","journal-title":"Nutrients"},{"key":"1126_CR121","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s11897-013-0153-9","volume":"10","author":"V Pureza","year":"2013","unstructured":"Pureza V, Florea VG. Mechanisms for cachexia in heart failure. Curr Heart Fail Rep. 2013;10:307\u201314.","journal-title":"Curr Heart Fail Rep"},{"key":"1126_CR122","doi-asserted-by":"publisher","first-page":"362","DOI":"10.12968\/hmed.2016.77.6.362","volume":"77","author":"CJ McAloon","year":"2016","unstructured":"McAloon CJ, O\u2019Hare P, Osman F, Randeva HS. The interplay between heart failure, metabolism and body composition. Br J\u00a0Hosp Med. 2016;77:362\u20134.","journal-title":"Br J\u00a0Hosp Med"},{"key":"1126_CR123","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/MCO.0b013e32835a8842","volume":"16","author":"DM Callahan","year":"2013","unstructured":"Callahan DM, Toth MJ. Skeletal muscle protein metabolism in human heart failure. Curr Opin Clin Nutr Metab Care. 2013;16:66\u201371.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"1126_CR124","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijcard.2011.09.079","volume":"162","author":"G Loncar","year":"2013","unstructured":"Loncar G, Fulster S, von Haehling S, Popovic V. Metabolism and the heart: an overview of muscle, fat, and bone metabolism in heart failure. Int J\u00a0Cardiol. 2013;162:77\u201385.","journal-title":"Int J\u00a0Cardiol"},{"key":"1126_CR125","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13539-014-0154-x","volume":"5","author":"JM Argiles","year":"2014","unstructured":"Argiles JM, Fontes-Oliveira CC, Toledo M, Lopez-Soriano FJ, Busquets S. Cachexia: a\u00a0problem of energetic inefficiency. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:279\u201386.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR126","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/jcsm.12061","volume":"6","author":"M Ponikowska","year":"2015","unstructured":"Ponikowska M, Tupikowska M, Kasztura M, Jankowska EA, Szepietowski JC. Deranged iron status in psoriasis: the impact of low body mass. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:358\u201364.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR127","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/ejhf.161","volume":"16","author":"TJ Yeo","year":"2014","unstructured":"Yeo TJ, Yeo PS, Ching-Chiew Wong R, Ong HY, Leong KT, Jaufeerally F, et al. Iron deficiency in a\u00a0multi-ethnic Asian population with and without heart failure: prevalence, clinical correlates, functional significance and prognosis. Eur J\u00a0Heart Fail. 2014;16:1125\u201332.","journal-title":"Eur J\u00a0Heart Fail"},{"key":"1126_CR128","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/jcsm.12086","volume":"7","author":"T Sente","year":"2016","unstructured":"Sente T, Van Berendoncks AM, Hoymans VY, Vrints CJ. Adiponectin resistance in skeletal muscle: pathophysiological implications in chronic heart failure. J\u00a0Cachexia Sarcopenia Muscle. 2016;7:261\u201374.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR129","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jcsm.12012","volume":"6","author":"K Cvan Trobec","year":"2015","unstructured":"Cvan Trobec K, Kerec Kos M, Trontelj J, Grabnar I, Tschirner A, Palus S, et\u00a0al. Influence of cancer cachexia on drug liver metabolism and renal elimination in rats. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:45\u201352.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR130","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/SPC.0000000000000030","volume":"8","author":"N Ebner","year":"2014","unstructured":"Ebner N, Elsner S, Springer J, von Haehling S. Molecular mechanisms and treatment targets of muscle wasting and cachexia in heart failure: an overview. Curr Opin Support Palliat Care. 2014;8:15\u201324.","journal-title":"Curr Opin Support Palliat Care"},{"key":"1126_CR131","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1161\/CIRCULATIONAHA.109.882068","volume":"121","author":"J Heineke","year":"2010","unstructured":"Heineke J, Auger-Messier M, Xu J, Sargent M, York A, Welle S, et al. Genetic deletion of myostatin from the heart prevents skeletal muscle atrophy in heart failure. Circulation. 2010;121:419\u201325.","journal-title":"Circulation"},{"key":"1126_CR132","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.bbrc.2014.12.057","volume":"457","author":"E Castillero","year":"2015","unstructured":"Castillero E, Akashi H, Wang C, Najjar M, Ji R, Kennel PJ, et\u00a0al. Cardiac myostatin upregulation occurs immediately after myocardial ischemia and is involved in skeletal muscle activation of atrophy. Biochem Biophys Res Commun. 2015;457:106\u201311.","journal-title":"Biochem Biophys Res Commun"},{"key":"1126_CR133","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s13539-011-0035-5","volume":"2","author":"Y Elkina","year":"2011","unstructured":"Elkina Y, von Haehling S, Anker SD, Springer J. The role of myostatin in muscle wasting: an overview. J\u00a0Cachexia Sarcopenia Muscle. 2011;2:143\u201351.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR134","doi-asserted-by":"publisher","DOI":"10.1080\/13685538.2016.1208166","author":"K Kulej-Lyko","year":"2016","unstructured":"Kulej-Lyko K, Majda J, von Haehling S, Doehner W, Lopuszanska M, Szklarska A, et al. Could gonadal and adrenal androgen deficiencies contribute to the depressive symptoms in men with systolic heart failure? Aging Male. 2016. doi:\n                    10.1080\/13685538.2016.1208166\n                    \n                  .","journal-title":"Aging Male"},{"key":"1126_CR135","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1111\/cen.13084","volume":"85","author":"SG Albert","year":"2016","unstructured":"Albert SG, Morley JE. Testosterone therapy, association with age, initiation and mode of therapy with cardiovascular events: a\u00a0systematic review. Clin Endocrinol (Oxf). 2016;85:436\u201343.","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"1126_CR136","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.mayocp.2016.02.014","volume":"91","author":"MR Dos Santos","year":"2016","unstructured":"Dos Santos MR, Sayegh AL, Bacurau AV, Arap MA, Brum PC, Pereira RM, et\u00a0al. Effect of exercise training and testosterone replacement on skeletal muscle wasting in patients with heart failure with testosterone deficiency. Mayo Clin Proc. 2016;91:575\u201386.","journal-title":"Mayo Clin. Proc."},{"key":"1126_CR137","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/jcsm.12084","volume":"6","author":"M Hatanaka","year":"2015","unstructured":"Hatanaka M, Konishi M, Ishida J, Saito M, Springer J. Novel mechanism of ghrelin therapy for cachexia. J\u00a0Cachexia Sarcopenia Muscle. 2015;6:393.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR138","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.lfs.2015.06.021","volume":"137","author":"Y Tanada","year":"2015","unstructured":"Tanada Y, Shioi T, Kato T, Kawamoto A, Okuda J, Kimura T. Branched-chain amino acids ameliorate heart failure with cardiac cachexia in rats. Life Sci. 2015;137:20\u20137.","journal-title":"Life Sci"},{"key":"1126_CR139","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12100","author":"AT Toneto","year":"2016","unstructured":"Toneto AT, Ferreira Ramos LA, Salomao EM, Tomasin R, Aereas MA, Gomes-Marcondes MC. Nutritional leucine supplementation attenuates cardiac failure in tumour-bearing cachectic animals. J\u00a0Cachexia Sarcopenia Muscle. 2016; doi:\n                    10.1002\/jcsm.12100\n                    \n                  .","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR140","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jcsm.12126","volume":"7","author":"AJ Stewart Coats","year":"2016","unstructured":"Stewart Coats AJ, Ho GF, Prabhash K, von Haehling S, Tilson J, Brown R, et al. Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a\u00a0randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial). J\u00a0Cachexia Sarcopenia Muscle. 2016;7:355\u201365.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"1126_CR141","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s13539-014-0153-y","volume":"5","author":"M Toledo","year":"2014","unstructured":"Toledo M, Springer J, Busquets S, Tschirner A, Lopez-Soriano FJ, Anker SD, et al. Formoterol in the treatment of experimental cancer cachexia: effects on heart function. J\u00a0Cachexia Sarcopenia Muscle. 2014;5:315\u201320.","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-016-1126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-016-1126-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-016-1126-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T18:03:35Z","timestamp":1589479415000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-016-1126-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":141,"journal-issue":{"issue":"S7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1126"],"URL":"https:\/\/doi.org\/10.1007\/s00508-016-1126-2","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]},"assertion":[{"value":"8 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.\u00a0Springer and S.D.\u00a0Anker declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}